Vol 34, (7):513 - 608
Cervical screening and human papillomavirus
Belinda Sheary, BMed, is a general practice registrar, Scone, New South Wales.
Linda Dayan, BMedSc, MBBS, MM (SexHlth), DipRACOG, MRCMA, FChSHM, is Head, Sexual Health Department, Royal North Shore Hospital and Manly Hospital Sydney, New South Wales.
BACKGROUND Cervical screening in Australia has been successful in reducing the incidence and mortality of cervical cancer. Human papilloma virus (HPV) is a common sexually transmitted infection and an integral agent in the development of cervical cancer.
OBJECTIVE This article discusses cervical screening, HPV infection and counselling women with low grade abnormalities on cervical cytology.
DISCUSSION For most women, detectable HPV infection is transient and subclinical. While HPV is a precursor to cervical cancer, this is a rare outcome of HPV infection. Minor abnormalities on cervical cytology reflecting acute HPV infection are common. Women with low grade Pap test abnormalities require reassurance and education about the prevalence and natural history of HPV.
Related files
Cervical screening and human papillomavirus (174Kb)
To download files on a PC: Right click the link and select 'Save Target As'.
To download files on a Mac: Hold Ctrl, click the link and select 'Download link to disk'.
Help with viewing files